All In MedTech

Device Trial Radar · NCT07158333

Mobile Cardiac Telemetry (MCT) Study

Last checked: Nov 19, 2026Latest source record: Nov 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

15

Actual

Start

Aug 5, 2025

Primary completion

Sep 12, 2025

Study completion Sep 12, 2025

Sponsor

Lead sponsor
Baxter Healthcare CorporationPublic (BAX)
Sponsor type
Industry
First posted
Sep 5, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

This study will be a single center, single arm, open-label, prospective study to evaluate adhesive performance of the Bardy Diagnostics' (BardyDx) MCT Patch up to 30 days of wear.

Conditions

  • Healthy

Interventions

  • Mobile Cardiac Telemetry (MCT System)Device

    MCT System without data transmission

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cumulative wear timeTime frame: 30 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Orange County Research Center

    Lake Forest, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.